223 related articles for article (PubMed ID: 22899781)
1. Linezolid-resistant clinical isolates of meticillin-resistant coagulase-negative staphylococci and Enterococcus faecium from China.
Cai JC; Hu YY; Zhang R; Zhou HW; Chen GX
J Med Microbiol; 2012 Nov; 61(Pt 11):1568-1573. PubMed ID: 22899781
[TBL] [Abstract][Full Text] [Related]
2. Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.
Chen H; Wu W; Ni M; Liu Y; Zhang J; Xia F; He W; Wang Q; Wang Z; Cao B; Wang H
Int J Antimicrob Agents; 2013 Oct; 42(4):317-21. PubMed ID: 23880167
[TBL] [Abstract][Full Text] [Related]
3. Emergence of cfr-harbouring coagulase-negative staphylococci among patients receiving linezolid therapy in two hospitals in China.
Yang XJ; Chen Y; Yang Q; Qu TT; Liu LL; Wang HP; Yu YS
J Med Microbiol; 2013 Jun; 62(Pt 6):845-850. PubMed ID: 23449871
[TBL] [Abstract][Full Text] [Related]
4. Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium.
Ntokou E; Stathopoulos C; Kristo I; Dimitroulia E; Labrou M; Vasdeki A; Makris D; Zakynthinos E; Tsakris A; Pournaras S
J Antimicrob Chemother; 2012 Aug; 67(8):1819-23. PubMed ID: 22532462
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing.
Tewhey R; Gu B; Kelesidis T; Charlton C; Bobenchik A; Hindler J; Schork NJ; Humphries RM
mBio; 2014 May; 5(3):e00894-14. PubMed ID: 24915435
[TBL] [Abstract][Full Text] [Related]
6. cfr-mediated linezolid-resistant clinical isolates of methicillin-resistant coagulase-negative staphylococci from China.
Song Y; Lv Y; Cui L; Li Y; Ke Q; Zhao Y
J Glob Antimicrob Resist; 2017 Mar; 8():1-5. PubMed ID: 27865985
[TBL] [Abstract][Full Text] [Related]
7. Cfr-mediated linezolid-resistance among methicillin-resistant coagulase-negative staphylococci from infections of humans.
Cui L; Wang Y; Li Y; He T; Schwarz S; Ding Y; Shen J; Lv Y
PLoS One; 2013; 8(2):e57096. PubMed ID: 23437319
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China.
Tian Y; Li T; Zhu Y; Wang B; Zou X; Li M
BMC Microbiol; 2014 Nov; 14():292. PubMed ID: 25420718
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology and molecular characteristics of linezolid-resistant
Ding L; Li P; Yang Y; Lin D; Xu X
J Med Microbiol; 2020 Aug; 69(8):1079-1088. PubMed ID: 32729813
[No Abstract] [Full Text] [Related]
10. Cluster of linezolid-resistant Enterococcus faecium ST117 in Norwegian hospitals.
Hegstad K; Longva JÅ; Hide R; Aasnæs B; Lunde TM; Simonsen GS
Scand J Infect Dis; 2014 Oct; 46(10):712-5. PubMed ID: 25134650
[TBL] [Abstract][Full Text] [Related]
11. [Linezolid-resistant Enterococcus faecium: the first G2576T mutation in Turkey].
Afşar I; Barış I; Sener AG; Köksal V; Demirci M
Mikrobiyol Bul; 2012 Jul; 46(3):516-8. PubMed ID: 22951666
[TBL] [Abstract][Full Text] [Related]
12. Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada.
Patel SN; Memari N; Shahinas D; Toye B; Jamieson FB; Farrell DJ
Diagn Microbiol Infect Dis; 2013 Dec; 77(4):350-3. PubMed ID: 24095643
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing linezolid-nonsusceptible coagulase-negative staphylococci dissemination among patients in the intensive care unit: a retrospective cohort study.
Papadimitriou-Olivgeris M; Giormezis N; Fligou F; Liakopoulos A; Marangos M; Anastassiou ED; Petinaki E; Filos KS; Spiliopoulou I
Chemotherapy; 2013; 59(6):420-6. PubMed ID: 25060224
[TBL] [Abstract][Full Text] [Related]
14. Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.
Swoboda S; Fritz S; Martignoni ME; Feldhues RA; Hoppe-Tichy T; Buchler MW; Geiss HK
J Antimicrob Chemother; 2005 Oct; 56(4):787-9. PubMed ID: 16143710
[TBL] [Abstract][Full Text] [Related]
15. Co-infection by two linezolid-resistant coagulase-negative staphylococci with two different resistance determinants.
Mazzariol A; Kocsis E; Bragagnolo L; Pellizzer G; Rassu M; Cornaglia G
Scand J Infect Dis; 2012 Dec; 44(12):978-81. PubMed ID: 22830638
[TBL] [Abstract][Full Text] [Related]
16. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus.
Morales G; Picazo JJ; Baos E; Candel FJ; Arribi A; Peláez B; Andrade R; de la Torre MA; Fereres J; Sánchez-García M
Clin Infect Dis; 2010 Mar; 50(6):821-5. PubMed ID: 20144045
[TBL] [Abstract][Full Text] [Related]
17. Linezolid-resistant enterococci in Greece: epidemiological characteristics.
Spiliopoulou I; Damani A; Chini V; Zerva L; Kolonitsiou F; Anastassiou ED; Petinaki E
Chemotherapy; 2011; 57(3):181-5. PubMed ID: 21474928
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci.
Tünger A; Aydemir S; Uluer S; Cilli F
Indian J Med Res; 2004 Dec; 120(6):546-52. PubMed ID: 15654141
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology of coagulase-negative bloodstream isolates: detection of Staphylococcus epidermidis ST2, ST7 and linezolid-resistant ST23.
Martínez-Meléndez A; Morfín-Otero R; Villarreal-Treviño L; Camacho-Ortíz A; González-González G; Llaca-Díaz J; Rodríguez-Noriega E; Garza-González E
Braz J Infect Dis; 2016; 20(5):419-28. PubMed ID: 27393769
[TBL] [Abstract][Full Text] [Related]
20. Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.
Jones RN; Ross JE; Bell JM; Utsuki U; Fumiaki I; Kobayashi I; Turnidge JD
Diagn Microbiol Infect Dis; 2009 Dec; 65(4):404-13. PubMed ID: 19913683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
